- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT05050162
Sammenligning av høydose cisplatin hver tredje uke med lavdose cisplatin ukentlig når kombinert med stråling for pasienter med avansert hode- og nakkekreft
Randomisert fase II/III studie av stråling med høydose cisplatin (100 mg/m2) hver tredje uke versus stråling med lavdose ukentlig cisplatin (40 mg/m2) for pasienter med lokalt avansert plateepitelkarsinom i hode og nakke ( SCCHN)
This phase II/III trial compares whether cisplatin given weekly with radiation therapy is better tolerated than cisplatin given every three weeks with radiation therapy for the treatment of head and neck cancer that has spread to other places in the body (advanced). The second part of this study will also help to find out if the cisplatin given weekly approach will extend patients' life by at least the same amount of time as the cisplatin given every three weeks approach. Cisplatin is in a class of medications known as platinum-containing compounds that work by killing, stopping or slowing the growth of cancer cells. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Radiation with low-dose cisplatin given weekly may be effective in shrinking or stabilizing head and neck cancer or preventing its recurrence.
Studieoversikt
Status
Forhold
- Klinisk stadium III HPV-mediert (p16-positiv) orofaryngealt karsinom AJCC v8
- Klinisk stadium IV HPV-mediert (p16-positiv) orofaryngealt karsinom AJCC v8
- Stadium III Orofaryngeal (p16-negativ) karsinom AJCC v8
- Stage IV Orofaryngeal (p16-negativ) karsinom AJCC v8
- Avansert plateepitelkarsinom i hode og nakke
- Avansert hypofarynx plateepitelkarsinom
- Avansert larynx plateepitelkarsinom
- Avansert orofarynx plateepitelkarsinom
- Fase IV Hode og nakke Kutan plateepitelkarsinom AJCC V8
- Fase III hode og nakke kutan plateepitelkarsinom AJCC V8
Detaljert beskrivelse
PRIMARY OBJECTIVES:
I. To determine whether radiation with cisplatin weekly is superior in terms of acute toxicity, as measured by the T-scores (TAME method), to radiation with cisplatin every 3 weeks for patients with locoregionally advanced squamous cell carcinoma of the head and neck (SCCHN). (Phase II) II. To determine whether radiation with cisplatin weekly is non-inferior to radiation with cisplatin every 3 weeks in terms of overall survival (OS) for patients with locoregionally advanced SCCHN. (Phase III) III. To determine whether radiation with cisplatin weekly is superior in terms of acute toxicity, as measured by the T-scores (TAME method), to radiation with cisplatin every 3 weeks for patients with locoregionally advanced SCCHN. (Phase III)
SECONDARY OBJECTIVES:
I. To assess and compare progression-free survival (PFS) between arms. II. To assess and compare locoregional failure and distant metastasis between arms.
III. To assess acute and late toxicity (Common Terminology Criteria for Adverse Events [CTCAE] version 5.0).
IV. To assess patient-reported outcomes quality of life (PRO/QOL), as measured by the Functional Assessment of Cancer Therapy-Head and Neck (FACT-H&N) (primary PRO), between arms.
V. To assess hearing loss, as measured by audiograms and the modified TUNE grading scale between arms.
VI. To assess hearing loss, as measured by speech audiometry Consonant-Nucleus-Consonant word scores and tympanometry (subject to the modified TUNE grading scale testing results; otherwise, it will be an exploratory objective).
VII. To assess hearing-related QOL as measured by the Hearing Handicap Inventory-Screening (HHIA-S) (secondary PRO), between arms.
VIII. To assess long-term PFS, OS, and toxicity between arms. IX. To assess 3-year restricted-mean survival time for OS and PFS between arms (if long-term update is warranted).
EXPLORATORY OBJECTIVE:
I. To collect blood and tissue specimens for future translational science studies. For instance, to examine how germline and somatic genetic variants, such as TP53, CDKN2A, PIK3CA, PTEN, NFE2L2, and KEAP1, may influence cisplatin-related efficacy and toxicity, and to assess the effect of regular nonsteroidal anti-inflammatory drugs (NSAIDs) use and genomic activation of PIK3CA (mutation or amplification) or loss of PTEN, the negative regulator of PI3K, on disease-free survival or overall survival.
OUTLINE: Patients are assigned to 1 of 2 arms.
ARM I (NON-OROPHARYNGEAL CANCER [OPC]/p16-NEGATIVE OPC group and p16-NEGATIVE OPC/CANCER OF UNKNOWN PRIMARY [CUP] group): Patients undergo radiation therapy over 5 fractions a week for a total of 33-35 fractions in the absence of disease progression or unacceptable toxicity. Patients also receive cisplatin intravenously (IV) once every 3 weeks (Q3W) (on days 1, 22, and 43) during radiation therapy in the absence of disease progression or unacceptable toxicity.
ARM II (NON-OROPHARYNGEAL CANCER [OPC]/p16-NEGATIVE OPC group and p16-NEGATIVE OPC/CANCER OF UNKNOWN PRIMARY [CUP] group): Patients undergo radiation therapy over 5 fractions a week for a total of 33-35 fractions in the absence of disease progression or unacceptable toxicity. Patients also receive cisplatin IV once a week (QW) for 7 weeks during radiation therapy in the absence of disease progression or unacceptable toxicity.
Patients undergo computed tomography (CT) scan, or magnetic resonance imaging (MRI) or position emission tomography (PET) scan throughout the study.
Studietype
Registrering (Faktiske)
Fase
- Fase 2
- Fase 3
Kontakter og plasseringer
Studiesteder
-
-
Ontario
-
Ottawa, Ontario, Canada, K1H 8L6
- Ottawa Hospital and Cancer Center-General Campus
-
Toronto, Ontario, Canada, M5G 2M9
- University Health Network-Princess Margaret Hospital
-
-
Quebec
-
Montreal, Quebec, Canada, H3H 2R9
- The Research Institute of the McGill University Health Centre (MUHC)
-
-
Saskatchewan
-
Regina, Saskatchewan, Canada, S4T 7T1
- Allan Blair Cancer Centre
-
Saskatoon, Saskatchewan, Canada, S7N 4H4
- Saskatoon Cancer Centre
-
-
-
-
Alabama
-
Mobile, Alabama, Forente stater, 36607
- Mobile Infirmary Medical Center
-
-
Arkansas
-
Jonesboro, Arkansas, Forente stater, 72401
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
-
Little Rock, Arkansas, Forente stater, 72205
- University of Arkansas for Medical Sciences
-
-
California
-
Anaheim, California, Forente stater, 92806
- Kaiser Permanente-Anaheim
-
Antioch, California, Forente stater, 94531
- Kaiser Permanente-Deer Valley Medical Center
-
Auburn, California, Forente stater, 95602
- Sutter Auburn Faith Hospital
-
Auburn, California, Forente stater, 95603
- Sutter Cancer Centers Radiation Oncology Services-Auburn
-
Bellflower, California, Forente stater, 90706
- Kaiser Permanente-Bellflower
-
Berkeley, California, Forente stater, 94704
- Alta Bates Summit Medical Center-Herrick Campus
-
Beverly Hills, California, Forente stater, 90211
- Tower Cancer Research Foundation
-
Carmichael, California, Forente stater, 95608
- Mercy San Juan Medical Center
-
Carmichael, California, Forente stater, 95608
- Mercy Cancer Center - Carmichael
-
Costa Mesa, California, Forente stater, 92627
- UC Irvine Health Cancer Center-Newport
-
Dublin, California, Forente stater, 94568
- Kaiser Permanente Dublin
-
Elk Grove, California, Forente stater, 95758
- Mercy Cancer Center - Elk Grove
-
Encinitas, California, Forente stater, 92024
- UC San Diego Health System - Encinitas
-
Fremont, California, Forente stater, 94538
- Kaiser Permanente-Fremont
-
Fremont, California, Forente stater, 94538
- Palo Alto Medical Foundation-Fremont
-
Fresno, California, Forente stater, 93720
- Kaiser Permanente-Fresno
-
Fresno, California, Forente stater, 93720
- Fresno Cancer Center
-
Fresno, California, Forente stater, 93720
- Kaiser Permanente Fresno Orchard Plaza
-
Irvine, California, Forente stater, 92618
- Kaiser Permanente-Irvine
-
Irvine, California, Forente stater, 92612
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
-
La Jolla, California, Forente stater, 92093
- UC San Diego Moores Cancer Center
-
Los Angeles, California, Forente stater, 90048
- Cedars-Sinai Medical Center
-
Los Angeles, California, Forente stater, 90027
- Kaiser Permanente Los Angeles Medical Center
-
Los Angeles, California, Forente stater, 90025
- The Angeles Clinic and Research Institute - West Los Angeles Office
-
Marysville, California, Forente stater, 95901
- Fremont - Rideout Cancer Center
-
Modesto, California, Forente stater, 95355
- Memorial Medical Center
-
Modesto, California, Forente stater, 95356
- Kaiser Permanente-Modesto
-
Mountain View, California, Forente stater, 94040
- Palo Alto Medical Foundation-Camino Division
-
Oakland, California, Forente stater, 94611
- Kaiser Permanente-Oakland
-
Oakland, California, Forente stater, 94611
- Kaiser Permanente Oakland-Broadway
-
Ontario, California, Forente stater, 91761
- Kaiser Permanente-Ontario
-
Orange, California, Forente stater, 92868
- UC Irvine Health/Chao Family Comprehensive Cancer Center
-
Palo Alto, California, Forente stater, 94304
- VA Palo Alto Health Care System
-
Palo Alto, California, Forente stater, 94304
- Stanford Cancer Institute Palo Alto
-
Palo Alto, California, Forente stater, 94301
- Palo Alto Medical Foundation Health Care
-
Rancho Cordova, California, Forente stater, 95670
- Kaiser Permanente-Rancho Cordova Cancer Center
-
Redwood City, California, Forente stater, 94063
- Kaiser Permanente- Marshall Medical Offices
-
Richmond, California, Forente stater, 94801
- Kaiser Permanente-Richmond
-
Rocklin, California, Forente stater, 95765
- Mercy Cancer Center - Rocklin
-
Rohnert Park, California, Forente stater, 94928
- Rohnert Park Cancer Center
-
Roseville, California, Forente stater, 95678
- The Permanente Medical Group-Roseville Radiation Oncology
-
Roseville, California, Forente stater, 95661
- Kaiser Permanente-Roseville
-
Roseville, California, Forente stater, 95661
- Sutter Cancer Centers Radiation Oncology Services-Roseville
-
Roseville, California, Forente stater, 95661
- Sutter Roseville Medical Center
-
Sacramento, California, Forente stater, 95816
- Sutter Medical Center Sacramento
-
Sacramento, California, Forente stater, 95817
- University of California Davis Comprehensive Cancer Center
-
Sacramento, California, Forente stater, 95814
- Kaiser Permanente Downtown Commons
-
Sacramento, California, Forente stater, 95823
- Kaiser Permanente-South Sacramento
-
Sacramento, California, Forente stater, 95823
- South Sacramento Cancer Center
-
Sacramento, California, Forente stater, 95816
- Mercy Cancer Center - Sacramento
-
San Diego, California, Forente stater, 92103
- UC San Diego Medical Center - Hillcrest
-
San Francisco, California, Forente stater, 94115
- Kaiser Permanente-San Francisco
-
San Francisco, California, Forente stater, 94158
- UCSF Medical Center-Mission Bay
-
San Francisco, California, Forente stater, 94115
- UCSF Medical Center-Mount Zion
-
San Jose, California, Forente stater, 95119
- Kaiser Permanente-Santa Teresa-San Jose
-
San Jose, California, Forente stater, 95124
- Stanford Cancer Center South Bay
-
San Leandro, California, Forente stater, 94577
- Kaiser Permanente San Leandro
-
San Luis Obispo, California, Forente stater, 93401
- Pacific Central Coast Health Center-San Luis Obispo
-
San Rafael, California, Forente stater, 94903
- Kaiser San Rafael-Gallinas
-
Santa Clara, California, Forente stater, 95051
- Kaiser Permanente Medical Center - Santa Clara
-
Santa Rosa, California, Forente stater, 95403
- Kaiser Permanente-Santa Rosa
-
Santa Rosa, California, Forente stater, 95403
- Sutter Pacific Medical Foundation
-
South San Francisco, California, Forente stater, 94080
- Kaiser Permanente Cancer Treatment Center
-
South San Francisco, California, Forente stater, 94080
- Kaiser Permanente-South San Francisco
-
Stockton, California, Forente stater, 95210
- Kaiser Permanente-Stockton
-
Sunnyvale, California, Forente stater, 94086
- Palo Alto Medical Foundation-Sunnyvale
-
Truckee, California, Forente stater, 96161
- Gene Upshaw Memorial Tahoe Forest Cancer Center
-
Vacaville, California, Forente stater, 95688
- Kaiser Permanente Medical Center-Vacaville
-
Vallejo, California, Forente stater, 94589
- Kaiser Permanente-Vallejo
-
Walnut Creek, California, Forente stater, 94596
- Kaiser Permanente-Walnut Creek
-
Woodland, California, Forente stater, 95695
- Woodland Memorial Hospital
-
-
Colorado
-
Colorado Springs, Colorado, Forente stater, 80923
- Saint Francis Cancer Center
-
Denver, Colorado, Forente stater, 80205
- Kaiser Permanente-Franklin
-
Denver, Colorado, Forente stater, 80218
- Saint Joseph Hospital - Cancer Centers of Colorado
-
Denver, Colorado, Forente stater, 80210
- AdventHealth Porter
-
Golden, Colorado, Forente stater, 80401
- Lutheran Hospital - Cancer Centers of Colorado
-
Lafayette, Colorado, Forente stater, 80026
- Kaiser Permanente-Rock Creek
-
Littleton, Colorado, Forente stater, 80122
- AdventHealth Littleton
-
Lone Tree, Colorado, Forente stater, 80124
- Kaiser Permanente-Lone Tree
-
Parker, Colorado, Forente stater, 80138
- AdventHealth Parker
-
-
District of Columbia
-
Washington D.C., District of Columbia, Forente stater, 20037
- George Washington University Medical Center
-
Washington D.C., District of Columbia, Forente stater, 20007
- MedStar Georgetown University Hospital
-
-
Florida
-
Aventura, Florida, Forente stater, 33180
- UM Sylvester Comprehensive Cancer Center at Aventura
-
Bay Pines, Florida, Forente stater, 33744
- Bay Pines VA Healthcare System
-
Coral Gables, Florida, Forente stater, 33146
- UM Sylvester Comprehensive Cancer Center at Coral Gables
-
Deerfield Beach, Florida, Forente stater, 33442
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach
-
Doral, Florida, Forente stater, 33166
- UM Sylvester Comprehensive Cancer Center at Doral
-
Miami, Florida, Forente stater, 33136
- University of Miami Miller School of Medicine-Sylvester Cancer Center
-
Miami, Florida, Forente stater, 33176
- UM Sylvester Comprehensive Cancer Center at Kendall
-
Plantation, Florida, Forente stater, 33324
- UM Sylvester Comprehensive Cancer Center at Plantation
-
Tampa, Florida, Forente stater, 33612
- Moffitt Cancer Center
-
Tampa, Florida, Forente stater, 33607
- Moffitt Cancer Center-International Plaza
-
Tampa, Florida, Forente stater, 33612
- Moffitt Cancer Center - McKinley Campus
-
Wesley Chapel, Florida, Forente stater, 33544
- Moffitt Cancer Center at Wesley Chapel
-
-
Georgia
-
Augusta, Georgia, Forente stater, 30912
- Augusta University Medical Center
-
-
Illinois
-
Aurora, Illinois, Forente stater, 60504
- Rush-Copley Medical Center
-
Bloomington, Illinois, Forente stater, 61704
- Illinois CancerCare-Bloomington
-
Canton, Illinois, Forente stater, 61520
- Illinois CancerCare-Canton
-
Carthage, Illinois, Forente stater, 62321
- Illinois CancerCare-Carthage
-
Centralia, Illinois, Forente stater, 62801
- Centralia Oncology Clinic
-
Chicago, Illinois, Forente stater, 60612
- John H Stroger Jr Hospital of Cook County
-
Danville, Illinois, Forente stater, 61832
- Carle at The Riverfront
-
Decatur, Illinois, Forente stater, 62526
- Decatur Memorial Hospital
-
Decatur, Illinois, Forente stater, 62526
- Cancer Care Specialists of Illinois - Decatur
-
Effingham, Illinois, Forente stater, 62401
- Crossroads Cancer Center
-
Effingham, Illinois, Forente stater, 62401
- Carle Physician Group-Effingham
-
Elmhurst, Illinois, Forente stater, 60126
- Elmhurst Memorial Hospital
-
Eureka, Illinois, Forente stater, 61530
- Illinois CancerCare-Eureka
-
Galesburg, Illinois, Forente stater, 61401
- Illinois CancerCare-Galesburg
-
Hines, Illinois, Forente stater, 60141
- Edward Hines Jr VA Hospital
-
Kewanee, Illinois, Forente stater, 61443
- Illinois CancerCare-Kewanee Clinic
-
Macomb, Illinois, Forente stater, 61455
- Illinois CancerCare-Macomb
-
Mattoon, Illinois, Forente stater, 61938
- Carle Physician Group-Mattoon/Charleston
-
Maywood, Illinois, Forente stater, 60153
- Loyola University Medical Center
-
Naperville, Illinois, Forente stater, 60540
- Edward Hospital/Cancer Center
-
O'Fallon, Illinois, Forente stater, 62269
- Cancer Care Center of O'Fallon
-
O'Fallon, Illinois, Forente stater, 62269
- HSHS Saint Elizabeth's Hospital
-
Ottawa, Illinois, Forente stater, 61350
- Illinois CancerCare-Ottawa Clinic
-
Pekin, Illinois, Forente stater, 61554
- Illinois CancerCare-Pekin
-
Peoria, Illinois, Forente stater, 61636
- Methodist Medical Center of Illinois
-
Peoria, Illinois, Forente stater, 61615
- Illinois CancerCare-Peoria
-
Peru, Illinois, Forente stater, 61354
- Illinois CancerCare-Peru
-
Princeton, Illinois, Forente stater, 61356
- Illinois CancerCare-Princeton
-
Rockford, Illinois, Forente stater, 61114
- UW Health Carbone Cancer Center Rockford
-
Springfield, Illinois, Forente stater, 62702
- Southern Illinois University School of Medicine
-
Springfield, Illinois, Forente stater, 62702
- Springfield Clinic
-
Springfield, Illinois, Forente stater, 62781
- Springfield Memorial Hospital
-
Urbana, Illinois, Forente stater, 61801
- Carle Cancer Center
-
Urbana, Illinois, Forente stater, 61801
- The Carle Foundation Hospital
-
Washington, Illinois, Forente stater, 61571
- Illinois CancerCare - Washington
-
-
Iowa
-
Ankeny, Iowa, Forente stater, 50023
- UI Health Care Mission Cancer and Blood - Ankeny Clinic
-
Clive, Iowa, Forente stater, 50325
- Mercy Cancer Center-West Lakes
-
Clive, Iowa, Forente stater, 50325
- UI Health Care Mission Cancer and Blood - West Des Moines Clinic
-
Creston, Iowa, Forente stater, 50801
- Greater Regional Medical Center
-
Des Moines, Iowa, Forente stater, 50309
- Iowa Methodist Medical Center
-
Des Moines, Iowa, Forente stater, 50314
- Mercy Medical Center - Des Moines
-
Des Moines, Iowa, Forente stater, 50314
- Broadlawns Medical Center
-
Des Moines, Iowa, Forente stater, 50316
- Iowa Lutheran Hospital
-
Des Moines, Iowa, Forente stater, 50309
- UI Health Care Mission Cancer and Blood - Des Moines Clinic
-
Des Moines, Iowa, Forente stater, 50314
- UI Health Care Mission Cancer and Blood - Laurel Clinic
-
Waukee, Iowa, Forente stater, 50263
- UI Health Care Mission Cancer and Blood - Waukee Clinic
-
West Des Moines, Iowa, Forente stater, 50266-7700
- Methodist West Hospital
-
West Des Moines, Iowa, Forente stater, 50266
- Mercy Medical Center-West Lakes
-
-
Kansas
-
Kansas City, Kansas, Forente stater, 66160
- University of Kansas Cancer Center
-
Olathe, Kansas, Forente stater, 66061
- The University of Kansas Cancer Center - Olathe
-
Overland Park, Kansas, Forente stater, 66210
- University of Kansas Cancer Center-Overland Park
-
Salina, Kansas, Forente stater, 67401
- Salina Regional Health Center
-
Topeka, Kansas, Forente stater, 66606
- University of Kansas Health System Saint Francis Campus
-
Westwood, Kansas, Forente stater, 66205
- University of Kansas Hospital-Westwood Cancer Center
-
-
Kentucky
-
Lexington, Kentucky, Forente stater, 40536
- University of Kentucky/Markey Cancer Center
-
Lexington, Kentucky, Forente stater, 40504
- Saint Joseph Radiation Oncology Resource Center
-
Lexington, Kentucky, Forente stater, 40509
- Saint Joseph Hospital East
-
Lexington, Kentucky, Forente stater, 40504
- Saint Joseph Hospital
-
Louisville, Kentucky, Forente stater, 40202
- The James Graham Brown Cancer Center at University of Louisville
-
Louisville, Kentucky, Forente stater, 40202
- Jewish Hospital
-
Louisville, Kentucky, Forente stater, 40245
- UofL Health Medical Center Northeast
-
-
Louisiana
-
New Orleans, Louisiana, Forente stater, 70112
- University Medical Center New Orleans
-
New Orleans, Louisiana, Forente stater, 70112
- Louisiana State University Health Science Center
-
-
Maine
-
Bath, Maine, Forente stater, 04530
- MaineHealth Coastal Cancer Treatment Center
-
Biddeford, Maine, Forente stater, 04005
- MaineHealth Maine Medical Center - Biddeford
-
Brewer, Maine, Forente stater, 04412
- Lafayette Family Cancer Center-EMMC
-
Portland, Maine, Forente stater, 04102
- MaineHealth Maine Medical Center - Portland
-
Sanford, Maine, Forente stater, 04073
- MaineHealth Cancer Care Center of York County
-
Sanford, Maine, Forente stater, 04073
- MaineHealth Cancer Care and IV Therapy - Sanford
-
Scarborough, Maine, Forente stater, 04074
- MaineHealth Maine Medical Center- Scarborough
-
South Portland, Maine, Forente stater, 04106
- MaineHealth Cancer Care and IV Therapy - South Portland
-
-
Maryland
-
Baltimore, Maryland, Forente stater, 21201
- University of Maryland/Greenebaum Cancer Center
-
Baltimore, Maryland, Forente stater, 21201
- Maryland Proton Treatment Center
-
Bel Air, Maryland, Forente stater, 21014
- UM Upper Chesapeake Medical Center
-
Columbia, Maryland, Forente stater, 21044
- Central Maryland Radiation Oncology in Howard County
-
Glen Burnie, Maryland, Forente stater, 21061
- UM Baltimore Washington Medical Center/Tate Cancer Center
-
-
Michigan
-
Ann Arbor, Michigan, Forente stater, 48109
- University of Michigan Rogel Cancer Center
-
Ann Arbor, Michigan, Forente stater, 48106
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor
-
Brighton, Michigan, Forente stater, 48114
- Trinity Health IHA Medical Group Hematology Oncology - Brighton
-
Brighton, Michigan, Forente stater, 48116
- University of Michigan - Brighton Center for Specialty Care
-
Brighton, Michigan, Forente stater, 48114
- Trinity Health Medical Center - Brighton
-
Brownstown, Michigan, Forente stater, 48183
- Henry Ford Cancer Institute-Downriver
-
Canton, Michigan, Forente stater, 48188
- Trinity Health IHA Medical Group Hematology Oncology - Canton
-
Canton, Michigan, Forente stater, 48188
- Trinity Health Medical Center - Canton
-
Chelsea, Michigan, Forente stater, 48118
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
-
Chelsea, Michigan, Forente stater, 48118
- Chelsea Hospital
-
Clarkston, Michigan, Forente stater, 48346
- Michigan Healthcare Professionals Clarkston
-
Clinton Township, Michigan, Forente stater, 48038
- Henry Ford Macomb Hospital-Clinton Township
-
Dearborn, Michigan, Forente stater, 48126
- Henry Ford Medical Center-Fairlane
-
Detroit, Michigan, Forente stater, 48202
- Henry Ford Hospital
-
Detroit, Michigan, Forente stater, 48236
- Henry Ford Health Saint John Hospital
-
Farmington Hills, Michigan, Forente stater, 48334
- Michigan Healthcare Professionals Farmington
-
Flint, Michigan, Forente stater, 48503
- Hurley Medical Center
-
Flint, Michigan, Forente stater, 48503
- Genesys Hurley Cancer Institute
-
Jackson, Michigan, Forente stater, 49201
- Allegiance Health
-
Livonia, Michigan, Forente stater, 48154
- Trinity Health Saint Mary Mercy Livonia Hospital
-
Macomb, Michigan, Forente stater, 48044
- Michigan Healthcare Professionals Macomb
-
Madison Heights, Michigan, Forente stater, 48071
- Michigan Healthcare Professionals Madison Heights
-
Novi, Michigan, Forente stater, 48377
- Henry Ford Medical Center-Columbus
-
Novi, Michigan, Forente stater, 48374
- Henry Ford Health Providence Novi Hospital
-
Pontiac, Michigan, Forente stater, 48341
- Trinity Health Saint Joseph Mercy Oakland Hospital
-
Pontiac, Michigan, Forente stater, 48341
- Michigan Healthcare Professionals Pontiac
-
Southfield, Michigan, Forente stater, 48075
- Henry Ford Health Providence Southfield Hospital
-
Troy, Michigan, Forente stater, 48098
- Michigan Healthcare Professionals Troy
-
Warren, Michigan, Forente stater, 48093
- Henry Ford Health Warren Hospital
-
West Bloomfield, Michigan, Forente stater, 48322
- Henry Ford West Bloomfield Hospital
-
Ypsilanti, Michigan, Forente stater, 48197
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
-
-
Minnesota
-
Bemidji, Minnesota, Forente stater, 56601
- Sanford Joe Lueken Cancer Center
-
Monticello, Minnesota, Forente stater, 55362
- Monticello Cancer Center
-
Saint Cloud, Minnesota, Forente stater, 56303
- Coborn Cancer Center at Saint Cloud Hospital
-
-
Mississippi
-
Columbus, Mississippi, Forente stater, 39705
- Baptist Memorial Hospital and Cancer Center-Golden Triangle
-
Grenada, Mississippi, Forente stater, 38901
- Baptist Cancer Center-Grenada
-
Gulfport, Mississippi, Forente stater, 39502
- Gulfport Memorial Hospital
-
Jackson, Mississippi, Forente stater, 39216
- University of Mississippi Medical Center
-
New Albany, Mississippi, Forente stater, 38652
- Baptist Memorial Hospital and Cancer Center-Union County
-
Oxford, Mississippi, Forente stater, 38655
- Baptist Memorial Hospital and Cancer Center-Oxford
-
Southhaven, Mississippi, Forente stater, 38671
- Baptist Memorial Hospital and Cancer Center-Desoto
-
-
Missouri
-
Cape Girardeau, Missouri, Forente stater, 63703
- Saint Francis Medical Center
-
Farmington, Missouri, Forente stater, 63640
- Parkland Health Center - Farmington
-
Jefferson City, Missouri, Forente stater, 65109
- MU Health Care Goldschmidt Cancer Center
-
Joplin, Missouri, Forente stater, 64804
- Freeman Health System
-
Kansas City, Missouri, Forente stater, 64154
- University of Kansas Cancer Center - North
-
Lee's Summit, Missouri, Forente stater, 64064
- University of Kansas Cancer Center - Lee's Summit
-
North Kansas City, Missouri, Forente stater, 64116
- University of Kansas Cancer Center at North Kansas City Hospital
-
Rolla, Missouri, Forente stater, 65401
- Mercy Clinic-Rolla-Cancer and Hematology
-
Rolla, Missouri, Forente stater, 65401
- Phelps Health Delbert Day Cancer Institute
-
Sainte Genevieve, Missouri, Forente stater, 63670
- Sainte Genevieve County Memorial Hospital
-
Springfield, Missouri, Forente stater, 65807
- CoxHealth South Hospital
-
Springfield, Missouri, Forente stater, 65804
- Mercy Hospital Springfield
-
St Louis, Missouri, Forente stater, 63131
- Missouri Baptist Medical Center
-
St Louis, Missouri, Forente stater, 63141
- Mercy Hospital Saint Louis
-
Sullivan, Missouri, Forente stater, 63080
- Missouri Baptist Sullivan Hospital
-
Sunset Hills, Missouri, Forente stater, 63127
- BJC Outpatient Center at Sunset Hills
-
-
Montana
-
Bozeman, Montana, Forente stater, 59715
- Bozeman Health Deaconess Hospital
-
Butte, Montana, Forente stater, 59701
- Saint James Community Hospital and Cancer Treatment Center
-
Great Falls, Montana, Forente stater, 59405
- Benefis Sletten Cancer Institute
-
Havre, Montana, Forente stater, 59501
- Hi-Line Sletten Cancer Center
-
-
Nebraska
-
Bellevue, Nebraska, Forente stater, 68123
- Nebraska Medicine-Bellevue
-
Omaha, Nebraska, Forente stater, 68198
- University of Nebraska Medical Center
-
Omaha, Nebraska, Forente stater, 68118
- Nebraska Medicine-Village Pointe
-
-
New Hampshire
-
Lebanon, New Hampshire, Forente stater, 03756
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
-
-
New Mexico
-
Albuquerque, New Mexico, Forente stater, 87106
- University of New Mexico Cancer Center
-
-
New York
-
Buffalo, New York, Forente stater, 14263
- Roswell Park Cancer Institute
-
Glens Falls, New York, Forente stater, 12801
- Glens Falls Hospital
-
Rochester, New York, Forente stater, 14642
- University of Rochester
-
Rochester, New York, Forente stater, 14620
- Highland Hospital
-
Stony Brook, New York, Forente stater, 11794
- Stony Brook University Medical Center
-
Webster, New York, Forente stater, 14580
- Wilmot Cancer Institute at Webster
-
-
North Carolina
-
Pinehurst, North Carolina, Forente stater, 28374
- FirstHealth of the Carolinas-Moore Regional Hospital
-
Supply, North Carolina, Forente stater, 28462
- Novant Cancer Institute Radiation Oncology - Supply
-
Wilkesboro, North Carolina, Forente stater, 28659
- Wake Forest Baptist Health - Wilkes Medical Center
-
Wilmington, North Carolina, Forente stater, 28401
- Novant Health New Hanover Regional Medical Center
-
Wilmington, North Carolina, Forente stater, 28401
- Novant Health Cancer Institute Radiation Oncology - Wilmington
-
Winston-Salem, North Carolina, Forente stater, 27157
- Wake Forest University Health Sciences
-
-
North Dakota
-
Bismarck, North Dakota, Forente stater, 58501
- Sanford Bismarck Medical Center
-
Fargo, North Dakota, Forente stater, 58122
- Sanford Roger Maris Cancer Center
-
Fargo, North Dakota, Forente stater, 58122
- Sanford Broadway Medical Center
-
-
Ohio
-
Akron, Ohio, Forente stater, 44304
- Summa Health System - Akron Campus
-
Avon, Ohio, Forente stater, 44011
- UH Seidman Cancer Center at UH Avon Health Center
-
Barberton, Ohio, Forente stater, 44203
- Summa Health System - Barberton Campus
-
Beavercreek, Ohio, Forente stater, 45431
- Indu and Raj Soin Medical Center
-
Centerville, Ohio, Forente stater, 45459
- Miami Valley Hospital South
-
Centerville, Ohio, Forente stater, 45459
- Dayton Physicians LLC-Miami Valley South
-
Cleveland, Ohio, Forente stater, 44106
- Case Western Reserve University
-
Cleveland, Ohio, Forente stater, 44109
- MetroHealth Medical Center
-
Cleveland, Ohio, Forente stater, 44195
- Cleveland Clinic Foundation
-
Cleveland, Ohio, Forente stater, 44111
- Cleveland Clinic Cancer Center/Fairview Hospital
-
Columbus, Ohio, Forente stater, 43210
- Ohio State University Comprehensive Cancer Center
-
Dayton, Ohio, Forente stater, 45409
- Miami Valley Hospital
-
Dayton, Ohio, Forente stater, 45415
- Miami Valley Hospital North
-
Dayton, Ohio, Forente stater, 45415
- Dayton Physician LLC - Englewood
-
Dayton, Ohio, Forente stater, 45409
- Premier Blood and Cancer Center
-
Franklin, Ohio, Forente stater, 45005-1066
- Atrium Medical Center-Middletown Regional Hospital
-
Franklin, Ohio, Forente stater, 45005
- Dayton Physicians LLC-Atrium
-
Greenville, Ohio, Forente stater, 45331
- Miami Valley Cancer Care and Infusion
-
Kettering, Ohio, Forente stater, 45429
- Kettering Medical Center
-
Mansfield, Ohio, Forente stater, 44906
- Cleveland Clinic Cancer Center Mansfield
-
Mayfield Heights, Ohio, Forente stater, 44124
- Hillcrest Hospital Cancer Center
-
Medina, Ohio, Forente stater, 44256
- Summa Health Medina Medical Center
-
Mentor, Ohio, Forente stater, 44060
- UH Seidman Cancer Center at Lake Health Mentor Campus
-
Ravenna, Ohio, Forente stater, 44266
- University Hospitals Portage Medical Center
-
Sandusky, Ohio, Forente stater, 44870
- North Coast Cancer Care
-
Strongsville, Ohio, Forente stater, 44136
- Cleveland Clinic Cancer Center Strongsville
-
Sylvania, Ohio, Forente stater, 43560
- ProMedica Flower Hospital
-
Toledo, Ohio, Forente stater, 43606
- ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital
-
Troy, Ohio, Forente stater, 45373
- Upper Valley Medical Center
-
Wooster, Ohio, Forente stater, 44691
- Cleveland Clinic Wooster Family Health and Surgery Center
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Forente stater, 73104
- University of Oklahoma Health Sciences Center
-
-
Pennsylvania
-
Bryn Mawr, Pennsylvania, Forente stater, 19010
- Bryn Mawr Hospital
-
Erie, Pennsylvania, Forente stater, 16544
- Saint Vincent Hospital
-
Hershey, Pennsylvania, Forente stater, 17033-0850
- Penn State Milton S Hershey Medical Center
-
Jefferson Hills, Pennsylvania, Forente stater, 15025
- Jefferson Hospital
-
Media, Pennsylvania, Forente stater, 19063
- Riddle Memorial Hospital
-
Monroeville, Pennsylvania, Forente stater, 15146
- Forbes Hospital
-
Paoli, Pennsylvania, Forente stater, 19301
- Paoli Memorial Hospital
-
Philadelphia, Pennsylvania, Forente stater, 19111
- Fox Chase Cancer Center
-
Philadelphia, Pennsylvania, Forente stater, 19140
- Temple University Hospital
-
Pittsburgh, Pennsylvania, Forente stater, 15212
- Allegheny General Hospital
-
Wexford, Pennsylvania, Forente stater, 15090
- Wexford Health and Wellness Pavilion
-
Wynnewood, Pennsylvania, Forente stater, 19096
- Lankenau Medical Center
-
-
South Carolina
-
Charleston, South Carolina, Forente stater, 29425
- Medical University of South Carolina
-
Greenwood, South Carolina, Forente stater, 29646
- Self Regional Healthcare
-
-
South Dakota
-
Sioux Falls, South Dakota, Forente stater, 57105
- Avera Cancer Institute
-
Sioux Falls, South Dakota, Forente stater, 57117-5134
- Sanford USD Medical Center - Sioux Falls
-
Sioux Falls, South Dakota, Forente stater, 57104
- Sanford Cancer Center Oncology Clinic
-
-
Tennessee
-
Collierville, Tennessee, Forente stater, 38017
- Baptist Memorial Hospital and Cancer Center-Collierville
-
Memphis, Tennessee, Forente stater, 38120
- Baptist Memorial Hospital and Cancer Center-Memphis
-
-
Texas
-
Baytown, Texas, Forente stater, 77521
- Houston Methodist San Jacinto Hospital
-
Cypress, Texas, Forente stater, 77429
- Houston Methodist Cypress Hospital
-
Houston, Texas, Forente stater, 77030
- Houston Methodist Hospital
-
Houston, Texas, Forente stater, 77030
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
-
Houston, Texas, Forente stater, 77070
- Methodist Willowbrook Hospital
-
Houston, Texas, Forente stater, 77030
- Michael E DeBakey VA Medical Center
-
Houston, Texas, Forente stater, 77030
- Ben Taub General Hospital
-
Houston, Texas, Forente stater, 77094
- Houston Methodist West Hospital
-
Nassau Bay, Texas, Forente stater, 77058
- Houston Methodist Saint John Hospital
-
Sugar Land, Texas, Forente stater, 77479
- Houston Methodist Sugar Land Hospital
-
The Woodlands, Texas, Forente stater, 77385
- Houston Methodist The Woodlands Hospital
-
-
Utah
-
American Fork, Utah, Forente stater, 84003
- American Fork Hospital / Huntsman Intermountain Cancer Center
-
Cedar City, Utah, Forente stater, 84720
- Sandra L Maxwell Cancer Center
-
Logan, Utah, Forente stater, 84321
- Logan Regional Hospital
-
Murray, Utah, Forente stater, 84107
- Intermountain Medical Center
-
Ogden, Utah, Forente stater, 84403
- McKay-Dee Hospital Center
-
Provo, Utah, Forente stater, 84604
- Utah Valley Regional Medical Center
-
Riverton, Utah, Forente stater, 84065
- Riverton Hospital
-
Salt Lake City, Utah, Forente stater, 84112
- Huntsman Cancer Institute/University of Utah
-
Salt Lake City, Utah, Forente stater, 84106
- Utah Cancer Specialists-Salt Lake City
-
Salt Lake City, Utah, Forente stater, 84143
- LDS Hospital
-
St. George, Utah, Forente stater, 84770
- Saint George Regional Medical Center
-
-
Vermont
-
Saint Johnsbury, Vermont, Forente stater, 05819
- Dartmouth Cancer Center - North
-
-
Virginia
-
Alexandria, Virginia, Forente stater, 22304
- Inova Alexandria Hospital
-
Fairfax, Virginia, Forente stater, 22031
- Inova Schar Cancer Institute
-
Fairfax, Virginia, Forente stater, 22033
- Inova Fair Oaks Hospital
-
-
Washington
-
Bellevue, Washington, Forente stater, 98004
- FHCC Overlake
-
Kirkland, Washington, Forente stater, 98034
- FHCC at EvergreenHealth
-
Seattle, Washington, Forente stater, 98195
- University of Washington Medical Center - Montlake
-
Seattle, Washington, Forente stater, 98109
- Fred Hutchinson Cancer Center
-
Seattle, Washington, Forente stater, 98133
- FHCC at Northwest Hospital
-
-
West Virginia
-
Charleston, West Virginia, Forente stater, 25304
- West Virginia University Charleston Division
-
-
Wisconsin
-
Antigo, Wisconsin, Forente stater, 54409
- Langlade Hospital and Cancer Center
-
Eau Claire, Wisconsin, Forente stater, 54701
- Marshfield Medical Center-EC Cancer Center
-
Johnson Creek, Wisconsin, Forente stater, 53038
- University of Wisconsin Carbone Cancer Center - Johnson Creek
-
La Crosse, Wisconsin, Forente stater, 54601
- Gundersen Lutheran Medical Center
-
Madison, Wisconsin, Forente stater, 53705
- William S Middleton VA Medical Center
-
Madison, Wisconsin, Forente stater, 53792
- University of Wisconsin Carbone Cancer Center - University Hospital
-
Madison, Wisconsin, Forente stater, 53718
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center
-
Marshfield, Wisconsin, Forente stater, 54449
- Marshfield Medical Center-Marshfield
-
Menomonee Falls, Wisconsin, Forente stater, 53051
- Froedtert Menomonee Falls Hospital
-
Milwaukee, Wisconsin, Forente stater, 53226
- Medical College of Wisconsin
-
Milwaukee, Wisconsin, Forente stater, 53295
- Zablocki Veterans Administration Medical Center
-
Minocqua, Wisconsin, Forente stater, 54548
- Marshfield Medical Center - Minocqua
-
Mukwonago, Wisconsin, Forente stater, 53149
- ProHealth D N Greenwald Center
-
Oak Creek, Wisconsin, Forente stater, 53154
- Drexel Town Square Health Center
-
Oconomowoc, Wisconsin, Forente stater, 53066
- ProHealth Oconomowoc Memorial Hospital
-
Rhinelander, Wisconsin, Forente stater, 54501
- Aspirus Cancer Care - James Beck Cancer Center
-
Rice Lake, Wisconsin, Forente stater, 54868
- Marshfield Medical Center-Rice Lake
-
Stevens Point, Wisconsin, Forente stater, 54482
- Marshfield Medical Center-River Region at Stevens Point
-
Stevens Point, Wisconsin, Forente stater, 54481
- Aspirus Cancer Care - Stevens Point
-
Waukesha, Wisconsin, Forente stater, 53188
- UW Cancer Center at ProHealth Care
-
Wausau, Wisconsin, Forente stater, 54401
- Aspirus Regional Cancer Center
-
West Bend, Wisconsin, Forente stater, 53095
- Froedtert West Bend Hospital/Kraemer Cancer Center
-
Weston, Wisconsin, Forente stater, 54476
- Marshfield Medical Center - Weston
-
Wisconsin Rapids, Wisconsin, Forente stater, 54494
- Aspirus Cancer Care - Wisconsin Rapids
-
-
-
-
-
Chai Wan, Hong Kong
- Pamela Youde Nethersole Eastern Hospital
-
-
-
-
Co Dublin
-
Dublin, Co Dublin, Irland, 6
- Saint Lukes Hospital
-
-
Co Galway
-
Galway, Co Galway, Irland
- University College Hospital Galway
-
-
-
-
-
Aarau, Sveits, 5001
- Kantonsspital Aarau
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
-
Pathologically (histologically or cytologically) proven diagnosis of SCCHN of the oropharynx, larynx, hypopharynx, or p16-positive unknown primary prior to registration; specimen from cervical lymph nodes with a well-defined primary site documented clinically or radiologically is acceptable; in patients with carcinoma of unknown primary this will be sufficient for pathologic confirmation without a clinically or radiographically defined primary site
- For patients with oropharyngeal cancer (OPC)/cancer of unknown primary (CUP):
P16 status based on local site immunohistochemical tissue staining is required. A cell block obtained from a fine needle aspiration (FNA) biopsy specimen may be used as the sole diagnostic tissue. Centers are encouraged to contact the pathology chair for clarification.
-
Note: Institutions must screen patients for p16 status by immunohistochemistry (IHC) in order to be eligible for the trial using a Clinical Laboratory Improvement Amendments (CLIA)-certified laboratory. A rigorous laboratory accreditation process similar to the United States (U.S.) CLIA certification, such as the provincial accreditation status offered by the Ontario Laboratory Accreditation (OLA) Program in Canada, the College of American Pathologists (CAP), or an equivalent accreditation in other countries, is acceptable.
-
The p16 results must be reported on the pathology report being submitted. The p16 positivity is defined as > 70% of tumor cells showing strong nuclear and/or cytoplasmic immunostaining with p16 antibody.
-
For patients with laryngeal and hypopharyngeal primaries: Analysis of p16 status is NOT required.
- Patients must have clinically or radiographically evident measurable disease at the primary site or at nodal stations. Simple tonsillectomy or local excision of the primary without removal of nodal disease is permitted, as is excision removing gross nodal disease but with intact primary site. Limited neck dissections retrieving =< 4 nodes are permitted and considered as non-therapeutic nodal excisions
- Clinical stage (American Joint Committee on Cancer [AJCC], 8th ed.), including no distant metastases based on the following diagnostic workup:
-
History/physical examination within 60 days prior to registration
-
One of the following imaging studies is required within 60 days prior to registration:
-
-
Computed tomography (CT) scan of neck (diagnostic quality with contrast, unless contraindicated) OR
-
Magnetic resonance imaging (MRI) of the neck (diagnostic quality with contrast, unless contraindicated) OR
-
Fludeoxyglucose F-18 (FDG)-positron emission tomography (PET)/CT of the neck; the CT component must be of diagnostic quality with contrast, unless contraindicated.
-
Note: A diagnostic quality CT or MRI with contrast or FDG-PET/CT scan of neck performed for the purposes of radiation planning may serve as both staging and planning tools
- One of the following imaging studies is required within 60 days prior to registration:
-
-
FDG-PET/CT of the chest; FDG-PET/CT scan is strongly preferred and highly recommended to be used for eligibility OR
-
Chest CT
- Exam with laryngopharyngoscopy (mirror or in office direct procedure acceptable) within 70 days prior to registration;
-
Eligibility by patient cohort;
- Non-OPC/p16-negative OPC Cohort; Tumor Site: Larynx/Hypopharynx; Clinical Staging (AJCC, 8th ed.): T3-4 N0 or T1-4 N1-3 T2 N0 (hypopharynx only)
- Tumor Site: p16-negative OPC; Clinical Staging (AJCC, 8th ed.): T2N1, T1-4 N2-3, or T3-4 N0-1
-
p16-positive OPC/CUP Cohort;
-
Tumor Site: OPC; Smoking Status: =< 10 pack-years; Clinical Staging (AJCC, 8th ed.): T1-3 N2-3 or T4 N0-3
-
Tumor Site: OPC; Smoking Status: > 10 pack-years; Clinical Staging (AJCC, 8th ed.): T1N2-3, T2N1-3, or T3-4 N0-3
-
Tumor Site: CUP; Smoking Status: Any; Clinical Staging (AJCC, 8th ed.): T0 N2-3 Note: Cigar and pipe tobacco consumption is not included in calculating the lifetime pack-years. Marijuana consumption is likewise not considered in this calculation. There is also no clear scientific evidence regarding the role of chewing tobacco-containing products in oropharyngeal cancer, although this is possibly more concerning given the proximity of the oral cavity and oropharynx. In any case, investigators should not count use of non-cigarette tobacco products in the pack-years calculation.
-
Age >= 18
-
Zubrod (Eastern Cooperative Oncology Group [ECOG]) performance status of 0-1 within 14 days prior to registration
-
Absolute neutrophil count (ANC) >= 1,500 cells/mm^3 (within 30 days prior to registration)
-
Platelets >= 75,000 cells/mm^3 (within 30 days prior to registration)
-
Hemoglobin >= 8.0 g/dL (within 30 days prior to registration)
- Note: The use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dL is acceptable)
-
Calculated creatinine clearance (CrCl) >= 50 mL/min by the Cockcroft-Gault formula (within 30 days prior to registration)
-
Total bilirubin =< 1.5 x institutional upper limit of normal (ULN) (within 30 days prior to registration) (not applicable to patients with known Gilbert's syndrome)
-
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< 1.5 x institutional ULN (within 30 days prior to registration)
-
Known human immunodeficiency virus (HIV) infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months and CD4 T Cell count > 200 cells/mm^3 are eligible for this trial. Testing is not required for entry into protocol
-
Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial
-
Negative urine or serum pregnancy test (in persons of childbearing potential) within 14 days prior to registration. Childbearing potential is defined as any person who has experienced menarche and who has not undergone surgical sterilization (hysterectomy or bilateral oophorectomy) or who is not postmenopausal. Menopause is defined clinically as 12 months of amenorrhea in a woman over 45 in the absence of other biological or physiological causes
-
Willing to use highly effective contraceptives for participants of childbearing potential (participants who may become pregnant or who may impregnate a partner) during therapy and for 14 months (females); for 11 months (males) following last dose of cisplatin; this inclusion is necessary because the treatment in this study may be significantly teratogenic.
-
The patient or a legally authorized representative must provide study-specific informed consent prior to study entry and, for patients treated in the United States (U.S.), authorization permitting release of personal health information
-
-
Exclusion Criteria:
-
Patients with oral cavity cancer, nasopharynx cancer, or p16-negative cancer of unknown primary (CUP)
-
Recurrence of the study cancer
-
Definitive clinical or radiologic evidence of distant metastatic disease
-
Prior systemic chemotherapy for the study cancer; note that prior chemotherapy for a different cancer is allowable, however, any prior exposure to cisplatin is excluded
-
Prior radiotherapy to the region of the study cancer that would result in overlap of radiation therapy fields
-
Severe, active co-morbidity defined as follows:
- Unstable angina requiring hospitalization in the last 6 months
- Myocardial infarction within the last 6 months
- New York Heart Association Functional Classification III/IV (Note: Patients with known history or current symptoms of cardiac disease, or history of treatment with cardiotoxic agents, should have a clinical risk assessment of cardiac function using the New York Heart Association Functional Classification.)
- Persistent grade 3-4 (CTCAE version 5.0) electrolyte abnormalities that cannot be reversed despite replacement as indicated by repeat testing
- Patient must not have an active infection requiring IV antibiotics prior to registration;
- Other chronic renal disease like nephrotic syndrome, that could be worsened by cisplatin therapy
- History of allogenic organ transplantation
- Any symptomatic peripheral sensory neuropathy grade >= 2 (CTCAE version 5.0);
-
Pregnancy and individuals unwilling to discontinue nursing
-
History of hypersensitivity to cisplatin or platinum-containing compounds
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Aktiv komparator: ARM I (radiation therapy, every 3 week cisplatin)
Patients undergo radiation therapy over 5 fractions a week for a total of 33-35 fractions in the absence of disease progression or unacceptable toxicity. Patients also receive cisplatin IV once Q3W (on days 1, 22, and 43) during radiation therapy in the absence of disease progression or unacceptable toxicity. Patients undergo CT scan, or MRI or PET scan throughout the study. |
Ancillary studies
Andre navn:
Undergo MRI
Andre navn:
Ancillary studies Undergo CT scan
Andre navn:
Undergo PET scan
Andre navn:
Undergo radiation therapy
Andre navn:
Given cisplatin IV every 3 weeks
Andre navn:
Given cisplatin IV weekly
Andre navn:
|
|
Eksperimentell: Arm II (radiation therapy, weekly cisplatin)
Patients undergo radiation therapy over 5 fractions a week for a total of 33-35 fractions in the absence of disease progression or unacceptable toxicity. Patients also receive weekly cisplatin IV QW for 7 weeks during radiation therapy in the absence of disease progression or unacceptable toxicity. Patients undergo CT scan, or MRI or PET scan throughout the study. |
Ancillary studies
Andre navn:
Undergo MRI
Andre navn:
Ancillary studies Undergo CT scan
Andre navn:
Undergo PET scan
Andre navn:
Undergo radiation therapy
Andre navn:
Given cisplatin IV every 3 weeks
Andre navn:
Given cisplatin IV weekly
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Incidence of acute toxicity (Phase II)
Tidsramme: Up to 180 days post-treatment
|
Measured by the T-scores. |
Up to 180 days post-treatment
|
|
Overall survival (OS) (Phase III)
Tidsramme: From randomization to death of any cause, assessed up to 9 years
|
OS rates will be estimated using the Kaplan-Meier method. |
From randomization to death of any cause, assessed up to 9 years
|
|
Incidence of acute toxicity (Phase III)
Tidsramme: Up to 180 days post-treatment
|
Measured by the T-scores. |
Up to 180 days post-treatment
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Lokoregionale sviktfrekvenser
Tidsramme: Opptil 9 år
|
Opptil 9 år
|
|
|
Fjern metastase
Tidsramme: Opptil 9 år
|
Opptil 9 år
|
|
|
Progression-free survival (PFS)
Tidsramme: From randomization to locoregional failure, distant metastasis, or death due to any cause, whichever occurs first, assessed up to 9 years
|
PFS rates will be estimated using the Kaplan-Meier method and between-arm differences compared using the log-rank test with a two-sided alpha of 0.05 (Kaplan 1958). |
From randomization to locoregional failure, distant metastasis, or death due to any cause, whichever occurs first, assessed up to 9 years
|
|
Restricted mean survival time (RMST) for OS
Tidsramme: At 3 years
|
Compared using a Wald-type test based on Kaplan-Meier estimates. Adjusted RMST estimates at 3 years and 95% confidence intervals will be provided using RMST regression with pseudo-observations. |
At 3 years
|
|
RMST for PFS
Tidsramme: At 3 years
|
Compared using a Wald-type test based on Kaplan-Meier estimates. Adjusted RMST estimates at 3 years and 95% confidence intervals will be provided using RMST regression with pseudo-observations. |
At 3 years
|
|
Incidence of acute toxicity
Tidsramme: Up to 180 days post-treatment
|
Measured by Common Terminology Criteria for Adverse Events (CTCAE) version (v) 5.0. |
Up to 180 days post-treatment
|
|
Incidence of late toxicity
Tidsramme: Up to 9 years
|
Measured by CTCAE v5.0. |
Up to 9 years
|
|
Incidence of late toxicity
Tidsramme: Up to 9 years
|
Measured by the A-scores. |
Up to 9 years
|
|
Quality of life
Tidsramme: At 6 months post-radiation therapy
|
Measured by Functional Assessment of Cancer Therapy Head and Neck. |
At 6 months post-radiation therapy
|
|
Hearing loss
Tidsramme: At 6 months post-radiation therapy
|
Measured by Hearing Handicap Inventory for Adults-Screening. |
At 6 months post-radiation therapy
|
|
Hearing loss (cochleotoxicity)
Tidsramme: At 6 months post-radiation therapy
|
Measured by audiograms and the modified TUNE grading scale. |
At 6 months post-radiation therapy
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Paul M Harari, NRG Oncology
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
- Stomatognatiske sykdommer
- Neoplasmer etter nettsted
- Neoplasmer
- Neoplasmer etter histologisk type
- Neoplasmer i hode og nakke
- Neoplasmer, kjertel og epitel
- Otorhinolaryngologiske sykdommer
- Faryngeale neoplasmer
- Otorhinolaryngologiske neoplasmer
- Faryngeale sykdommer
- Karsinom
- Orofaryngeale neoplasmer
- Undersøkelsesteknikker
- Terapeutikk
- Fysiske fenomener
- Uorganiske kjemikalier
- Klorforbindelser
- Nitrogenforbindelser
- Elementer
- Metaller
- Kjemisteknikker, analytisk
- Spektrumanalyse
- Metaller, tunge
- Platinumforbindelser
- Overgangselementer
- Cisplatin
- 1,2-diaminocykloheksanplatina II sitrat
- Strålebehandling
- Stråling
- Magnetisk resonansspektroskopi
- Platinum
Andre studie-ID-numre
- NRG-HN009
- U10CA180868 (U.S. NIH-stipend/kontrakt)
- NRG-HN009 (Annen identifikator: CTEP)
- NCI-2021-08925 (Registeridentifikator: CTRP (Clinical Trial Reporting Program))
- NRG-HN009 (Annen identifikator: NRG Oncology)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-delingstidsramme
NCI is committed to sharing data in accordance with NIH policy. For more details on how clinical trial data is shared, access the link to the NIH data sharing policy page.
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .